|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of right-of-use lease assets | |||||
| Stock-based compensation | |||||
| Loss on investment | |||||
| Gain on divestiture of business | |||||
| Other non-cash items, net | |||||
| Provision (benefit) from deferred income taxes | |||||
| Changes in operating assets and liabilities, excluding the effects of acquisitions: | |||||
| Accounts receivable | |||||
| Accounts payable and accrued expenses | |||||
| Accrued compensation and benefits | |||||
| Deferred revenue | |||||
| Accrued income taxes | |||||
| Other current assets and prepaid expenses | |||||
| Operating lease liabilities | |||||
| Other noncurrent assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Additions to property and equipment | |||||
| Purchases of short- and long-term marketable securities | |||||
| Proceeds from sales of short- and long-term marketable securities | |||||
| Proceeds from maturities of short- and long-term marketable securities | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Proceeds from sale of investments | |||||
| Purchases of investments | |||||
| Purchase of intangible assets | |||||
| Settlement of net investment hedges | |||||
| Divestitures of businesses and assets, net | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowings under credit facility | |||||
| Repayments of senior notes | |||||
| Repayments of borrowings under credit facility and acquired debt | |||||
| Repurchases of common stock | |||||
| Proceeds from issuance of common stock | |||||
| Payments of withholding taxes in connection with stock-based awards | |||||
| Payments of principal for financing leases | |||||
| Credit facility origination costs | |||||
| Payment of deferred acquisition consideration | |||||
| Other financing activity | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
Loading...